Document ID: chunk:federal_register_of_legislation:F2025C00183:clause:1_73061
Version: federal_register_of_legislation:F2025C00183
Segment Type: clause
Provision Reference: sch 1 cl 73061
Character Range: 255711–256217

73061              Immunocytochemical examination of material obtained by procedures described in items 73045, 73047, 73049, 73051, 73062, 73063, 73066 and 73067 for the characterisation of a malignancy by immunofluorescence, immunoperoxidase or other labelled antibody techniques with multiple antigenic specificities per specimen—one to 3 of the following antibodies:                     51.20
                   (a) oestrogen;
                   (b) progesterone;
                   (c) c‑erb‑B2 (HER2)